HomeCompareBBP vs SCHD

BBP vs SCHD: Dividend Comparison 2026

BBP yields 2.55% · SCHD yields 3.46%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCHD wins by $5.5K in total portfolio value
10 years
BBP
BBP
● Live price
2.55%
Share price
$78.41
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.5K
Annual income
$300.71
Full BBP calculator →
SCHD
Schwab U.S. Dividend Equity ETF
● Live price
3.46%
Share price
$30.48
Annual div
$1.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$425.95
Full SCHD calculator →

Portfolio growth — BBP vs SCHD

📍 SCHD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBBPSCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BBP + SCHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BBP pays
SCHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BBP
Annual income on $10K today (after 15% tax)
$216.81/yr
After 10yr DRIP, annual income (after tax)
$255.60/yr
SCHD
Annual income on $10K today (after 15% tax)
$294.40/yr
After 10yr DRIP, annual income (after tax)
$362.06/yr
At 15% tax rate, SCHD beats the other by $106.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BBP + SCHD for your $10,000?

BBP: 50%SCHD: 50%
100% SCHD50/50100% BBP
Portfolio after 10yr
$26.3K
Annual income
$363.33/yr
Blended yield
1.38%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BBP buys
0
SCHD buys
3
PoliticianChamberTickerTypeAmountDate
Virginia Foxx🏢 House$SCHD▼ Sell$50,001 - $100,0002023-03-08
Steve Cohen🏢 House$SCHD▲ Buy$50,001 - $100,0002022-07-29
Hakeem S. Jeffries🏢 House$SCHD▲ Buy$15,001 - $50,0002021-04-12
Mikie Sherrill🏢 House$SCHD▲ Buy$100,001 - $250,0002020-02-21
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBBPSCHD
Forward yield2.55%3.46%
Annual dividend / share$2.00$1.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$23.5K$29.0K
Annual income after 10y$300.71$425.95
Total dividends collected$2.8K$3.9K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BBP vs SCHD ($10,000, DRIP)

YearBBP PortfolioBBP Income/yrSCHD PortfolioSCHD Income/yrGap
1← crossover$10,955$255.07$11,226$346.36$271.00SCHD
2$11,983$261.15$12,572$357.38$589.00SCHD
3$13,089$266.97$14,046$367.84$957.00SCHD
4$14,278$272.53$15,660$377.73$1.4KSCHD
5$15,555$277.83$17,425$387.07$1.9KSCHD
6$16,927$282.88$19,354$395.86$2.4KSCHD
7$18,399$287.69$21,461$404.13$3.1KSCHD
8$19,979$292.26$23,762$411.89$3.8KSCHD
9$21,674$296.60$26,272$419.15$4.6KSCHD
10$23,492$300.71$29,010$425.95$5.5KSCHD

BBP vs SCHD: Complete Analysis 2026

BBPStock

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.

Full BBP Calculator →

SCHDETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →
📬

Get this BBP vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BBP vs JEPIBBP vs OBBP vs KOBBP vs MAINBBP vs VYMBBP vs DGROBBP vs VIGBBP vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.